GENETIC-DIFFERENCES IN PHENYTOIN PHARMACOKINETICS - INVIVO CLEARANCE AND INVITRO METABOLISM AMONG INBRED STRAINS OF MICE

被引:31
作者
ATLAS, SA [1 ]
ZWEIER, JL [1 ]
NEBERT, DW [1 ]
机构
[1] NICHHD,DEV PHARMACOL BRANCH,BLDG ID,ROOM 13-N-266,BETHESDA,MD 20205
来源
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS | 1980年 / 1卷 / 05期
关键词
D O I
10.1159/000455547
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:281 / 304
页数:24
相关论文
共 102 条
[31]  
GIBSON JE, 1968, P SOC EXP BIOL MED, V128, P905
[32]  
GLAZKO AJ, 1969, CLIN PHARMACOL THER, V10, P498
[33]  
GOLDSTEIN A, 1969, PRINCIPLES DRUG ACTI, P106
[34]   SULTHIAME (OSPOLOT) AS INHIBITOR OF DIPHENYLHYDANTOIN METABOLISM [J].
HANSEN, JM ;
KRISTENSEN, M ;
SKOVSTED, L .
EPILEPSIA, 1968, 9 (01) :17-+
[35]  
HANSEN JM, 1966, LANCET, V2, P265
[36]   FETAL HYDANTOIN SYNDROME [J].
HANSON, JW ;
SMITH, DW .
JOURNAL OF PEDIATRICS, 1975, 87 (02) :285-290
[37]   RISKS TO OFFSPRING OF WOMEN TREATED WITH HYDANTOIN ANTICONVULSANTS, WITH EMPHASIS ON FETAL HYDANTOIN SYNDROME [J].
HANSON, JW ;
MYRIANTHOPOULOS, NC ;
SEDGWICK, MA ;
SMITH, DW .
JOURNAL OF PEDIATRICS, 1976, 89 (04) :662-668
[38]  
HARBISON RD, 1970, J PHARMACOL EXP THER, V175, P283
[39]  
HARBISON RD, 1969, FED PROC, V28, P676
[40]  
HARINASUTA U, 1968, JAMA-J AM MED ASSOC, V203, P111